Julius Knowles - Dec 1, 2021 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
Director
Signature
/s/ Keith Regnante, Attorney-in-Fact
Stock symbol
KROS
Transactions as of
Dec 1, 2021
Transactions value $
-$2,577,376
Form type
4
Date filed
12/3/2021, 04:05 PM
Previous filing
Nov 3, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Sale -$227K -4.24K -1.06% $53.48 395K Dec 1, 2021 See footnote F1, F2, F3
transaction KROS Common Stock Sale -$148K -2.77K -1.02% $53.48 268K Dec 1, 2021 See footnote F1, F2, F4
transaction KROS Common Stock Sale -$283K -5.17K -1.31% $54.67 390K Dec 1, 2021 See footnote F1, F3, F5
transaction KROS Common Stock Sale -$184K -3.37K -1.26% $54.67 264K Dec 1, 2021 See footnote F1, F4, F5
transaction KROS Common Stock Sale -$141K -2.53K -0.65% $55.71 387K Dec 1, 2021 See footnote F1, F3, F6
transaction KROS Common Stock Sale -$91.9K -1.65K -0.62% $55.71 263K Dec 1, 2021 See footnote F1, F4, F6
transaction KROS Common Stock Sale -$88.1K -1.57K -0.4% $56.27 386K Dec 1, 2021 See footnote F1, F3, F7
transaction KROS Common Stock Sale -$57.5K -1.02K -0.39% $56.27 262K Dec 1, 2021 See footnote F1, F4, F7
transaction KROS Common Stock Sale -$4.11K -79 -0.02% $51.99 386K Dec 2, 2021 See footnote F1, F3, F8
transaction KROS Common Stock Sale -$2.7K -52 -0.02% $52.00* 261K Dec 2, 2021 See footnote F1, F4, F8
transaction KROS Common Stock Sale -$339K -6.37K -1.65% $53.17 379K Dec 2, 2021 See footnote F1, F3, F9
transaction KROS Common Stock Sale -$221K -4.16K -1.59% $53.17 257K Dec 2, 2021 See footnote F1, F4, F9
transaction KROS Common Stock Sale -$471K -8.75K -2.31% $53.86 371K Dec 2, 2021 See footnote F1, F3, F10
transaction KROS Common Stock Sale -$307K -5.71K -2.22% $53.86 252K Dec 2, 2021 See footnote F1, F4, F10
transaction KROS Common Stock Sale -$7.54K -138 -0.04% $54.67 370K Dec 2, 2021 See footnote F1, F3, F11
transaction KROS Common Stock Sale -$4.92K -90 -0.04% $54.67 252K Dec 2, 2021 See footnote F1, F4, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.04 to $54.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8), (9), (10) and (11).
F3 The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF I.
F4 The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF II.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.055 to $55.05 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.055 to $56.05 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.06 to $57.02 inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.58 to $52.57 inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.61 to $53.605 inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.625 to $54.43 inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.665 to $54.69 inclusive.